• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向病毒感染中的炎症小体激活:一种治疗方法?

Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution?

机构信息

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macao 999078, China.

State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Av. Wai Long, Taipa, Macao 999078, China.

出版信息

Viruses. 2023 Jun 27;15(7):1451. doi: 10.3390/v15071451.

DOI:10.3390/v15071451
PMID:37515138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10384481/
Abstract

Inflammasome activation is exclusively involved in sensing activation of innate immunity and inflammatory response during viral infection. Accumulating evidence suggests that the manipulation of inflammasome assembly or its interaction with viral proteins are critical factors in viral pathogenesis. Results from pilot clinical trials show encouraging results of NLRP3 inflammasome suppression in reducing mortality and morbidity in SARS-CoV-2-infected patients. In this article, we summarize the up-to-date understanding of inflammasomes, including NLRP3, AIM2, NLRP1, NLRP6, and NLRC4 in various viral infections, with particular focus on RNA viruses such as SARS-CoV-2, HIV, IAV, and Zika virus and DNA viruses such as herpes simplex virus 1. We also discuss the current achievement of the mechanisms involved in viral infection-induced inflammatory response, host defense, and possible therapeutic solutions.

摘要

炎症小体的激活专门参与感知病毒感染期间固有免疫和炎症反应的激活。越来越多的证据表明,炎症小体组装的操纵或其与病毒蛋白的相互作用是病毒发病机制中的关键因素。初步临床试验结果表明,NLRP3 炎症小体抑制可降低 SARS-CoV-2 感染患者的死亡率和发病率,结果令人鼓舞。在本文中,我们总结了对各种病毒感染中炎症小体(包括 NLRP3、AIM2、NLRP1、NLRP6 和 NLRC4)的最新认识,特别关注 SARS-CoV-2、HIV、IAV 和寨卡病毒等 RNA 病毒以及单纯疱疹病毒 1 等 DNA 病毒。我们还讨论了病毒感染诱导的炎症反应、宿主防御和可能的治疗解决方案中涉及的机制的当前成就。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62ca/10384481/d6a1d1a3f4a0/viruses-15-01451-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62ca/10384481/4d56f2af9506/viruses-15-01451-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62ca/10384481/6fedc331a4f0/viruses-15-01451-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62ca/10384481/d6a1d1a3f4a0/viruses-15-01451-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62ca/10384481/4d56f2af9506/viruses-15-01451-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62ca/10384481/6fedc331a4f0/viruses-15-01451-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62ca/10384481/d6a1d1a3f4a0/viruses-15-01451-g003.jpg

相似文献

1
Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution?靶向病毒感染中的炎症小体激活:一种治疗方法?
Viruses. 2023 Jun 27;15(7):1451. doi: 10.3390/v15071451.
2
Inflammasomes on the Crossroads of Innate Immune Recognition and Metabolic Control.炎症小体在先天免疫识别和代谢控制的十字路口。
Cell Metab. 2017 Jul 5;26(1):71-93. doi: 10.1016/j.cmet.2017.06.018.
3
DDX3X coordinates host defense against influenza virus by activating the NLRP3 inflammasome and type I interferon response.DDX3X 通过激活 NLRP3 炎性体和 I 型干扰素反应来协调宿主对抗流感病毒的防御。
J Biol Chem. 2021 Jan-Jun;296:100579. doi: 10.1016/j.jbc.2021.100579. Epub 2021 Mar 23.
4
Zika virus infection induces host inflammatory responses by facilitating NLRP3 inflammasome assembly and interleukin-1β secretion.寨卡病毒感染通过促进 NLRP3 炎性小体组装和白细胞介素-1β分泌诱导宿主炎症反应。
Nat Commun. 2018 Jan 9;9(1):106. doi: 10.1038/s41467-017-02645-3.
5
Inflammasomes during SARS-CoV-2 infection and development of their corresponding inhibitors.SARS-CoV-2 感染期间的炎症小体及其相应抑制剂的研究进展。
Front Cell Infect Microbiol. 2023 Jun 9;13:1218039. doi: 10.3389/fcimb.2023.1218039. eCollection 2023.
6
Innate Immune Response and Inflammasome Activation During SARS-CoV-2 Infection.SARS-CoV-2 感染期间的先天免疫反应和炎症小体激活。
Inflammation. 2022 Oct;45(5):1849-1863. doi: 10.1007/s10753-022-01651-y. Epub 2022 Aug 11.
7
Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein.Sars-CoV-2 包膜蛋白对 NLRP3 炎性小体的调节。
Sci Rep. 2021 Dec 24;11(1):24432. doi: 10.1038/s41598-021-04133-7.
8
Myxoma virus lacking the pyrin-like protein M013 is sensed in human myeloid cells by both NLRP3 and multiple Toll-like receptors, which independently activate the inflammasome and NF-κB innate response pathways.缺失pyrin 样蛋白 M013 的粘液瘤病毒可被人髓系细胞中的 NLRP3 和多种 Toll 样受体识别,这些受体可独立激活炎症小体和 NF-κB 先天反应途径。
J Virol. 2011 Dec;85(23):12505-17. doi: 10.1128/JVI.00410-11. Epub 2011 Sep 28.
9
PB1-F2 protein of highly pathogenic influenza A (H7N9) virus selectively suppresses RNA-induced NLRP3 inflammasome activation through inhibition of MAVS-NLRP3 interaction.高致病性甲型流感病毒(H7N9)的 PB1-F2 蛋白通过抑制 MAVS-NLRP3 相互作用选择性抑制 RNA 诱导的 NLRP3 炎症小体激活。
J Leukoc Biol. 2020 Nov;108(5):1655-1663. doi: 10.1002/JLB.4AB0420-694R. Epub 2020 May 9.
10
NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity.NLRP3 炎性小体在 COVID-19 中的激活:危险因素与疾病严重程度之间的关联。
Microbes Infect. 2022 Feb;24(1):104913. doi: 10.1016/j.micinf.2021.104913. Epub 2021 Nov 25.

引用本文的文献

1
Targeting inflammasomes as an immunotherapeutic strategy for cancer.以炎性小体为靶点作为癌症的免疫治疗策略。
J Transl Med. 2025 Jun 8;23(1):634. doi: 10.1186/s12967-025-06665-2.
2
Antiviral Effect of Erdosteine in Cells Infected with Human Respiratory Viruses.厄多司坦对人呼吸道病毒感染细胞的抗病毒作用。
Pathogens. 2025 Apr 15;14(4):388. doi: 10.3390/pathogens14040388.
3
Genetic Variants in the NOD-like Receptor Signaling Pathway Are Associated with HIV-1/AIDS in a Northern Chinese Population.核苷酸结合寡聚化结构域样受体信号通路中的基因变异与中国北方人群的HIV-1/艾滋病相关。

本文引用的文献

1
The impact of COVID-19 on hospitalization outcomes of patients with acute myocardial infarction in the USA.新冠病毒病对美国急性心肌梗死患者住院治疗结果的影响。
Am Heart J Plus. 2023 Aug;32:100305. doi: 10.1016/j.ahjo.2023.100305. Epub 2023 Jun 12.
2
Hepatitis E virus infection remodels the mature tRNAome in macrophages to orchestrate NLRP3 inflammasome response.戊型肝炎病毒感染重塑巨噬细胞中的成熟 tRNA 组以协调 NLRP3 炎性体反应。
Proc Natl Acad Sci U S A. 2023 Jun 20;120(25):e2304445120. doi: 10.1073/pnas.2304445120. Epub 2023 Jun 12.
3
Host-specific sensing of coronaviruses and picornaviruses by the CARD8 inflammasome.
Int J Mol Sci. 2025 Apr 8;26(8):3484. doi: 10.3390/ijms26083484.
4
Inflammasomes and autophagy in cancer: unlocking targeted therapies.癌症中的炎性小体与自噬:开启靶向治疗
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 1. doi: 10.1007/s00210-025-04184-x.
5
Neuroinflammation, Blood-Brain Barrier, and HIV Reservoirs in the CNS: An In-Depth Exploration of Latency Mechanisms and Emerging Therapeutic Strategies.中枢神经系统中的神经炎症、血脑屏障与HIV储存库:潜伏期机制及新兴治疗策略的深入探索
Viruses. 2025 Apr 16;17(4):572. doi: 10.3390/v17040572.
6
Successful Treatment With High-Dose Colchicine of a 101-Year-Old Patient Diagnosed With COVID-19 After an Emergency Cholecystectomy.一名101岁患者在急诊胆囊切除术后被诊断为新冠肺炎,高剂量秋水仙碱治疗成功
Cureus. 2024 Jun 26;16(6):e63201. doi: 10.7759/cureus.63201. eCollection 2024 Jun.
7
High-Dose Colchicine: Key Factor in the Treatment of Morbidly Obese COVID-19 Patients.大剂量秋水仙碱:治疗病态肥胖COVID-19患者的关键因素。
Cureus. 2024 Apr 13;16(4):e58164. doi: 10.7759/cureus.58164. eCollection 2024 Apr.
8
Herpes Simplex Virus ICP27 Protein Inhibits AIM 2-Dependent Inflammasome Influencing Pro-Inflammatory Cytokines Release in Human Pigment Epithelial Cells (hTert-RPE 1).单纯疱疹病毒 ICP27 蛋白抑制 AIM2 依赖性炎性体影响人视网膜色素上皮细胞(hTert-RPE1)中促炎细胞因子的释放。
Int J Mol Sci. 2024 Apr 23;25(9):4608. doi: 10.3390/ijms25094608.
9
Inflammasome-Related Genetic Polymorphisms as Severity Biomarkers of COVID-19.炎症小体相关遗传多态性作为 COVID-19 严重程度的生物标志物。
Int J Mol Sci. 2024 Mar 27;25(7):3731. doi: 10.3390/ijms25073731.
10
The interaction of inflammasomes and gut microbiota: novel therapeutic insights.炎症小体与肠道微生物群的相互作用:新的治疗见解。
Cell Commun Signal. 2024 Apr 2;22(1):209. doi: 10.1186/s12964-024-01504-1.
CARD8 炎性小体对冠状病毒和小核糖核酸病毒的宿主特异性感应。
PLoS Biol. 2023 Jun 8;21(6):e3002144. doi: 10.1371/journal.pbio.3002144. eCollection 2023 Jun.
4
NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs.NLRP12-PANoptosome 响应血红素和 PAMPs 激活 PANoptosis 和病理学。
Cell. 2023 Jun 22;186(13):2783-2801.e20. doi: 10.1016/j.cell.2023.05.005. Epub 2023 Jun 1.
5
A 360° view of the inflammasome: Mechanisms of activation, cell death, and diseases. inflammasome 的全景:激活机制、细胞死亡与疾病。
Cell. 2023 May 25;186(11):2288-2312. doi: 10.1016/j.cell.2023.04.025.
6
Bat ASC2 suppresses inflammasomes and ameliorates inflammatory diseases.蝙蝠 ASC2 抑制炎症小体并改善炎症性疾病。
Cell. 2023 May 11;186(10):2144-2159.e22. doi: 10.1016/j.cell.2023.03.036.
7
Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19.鼻病毒诱导的上皮细胞 RIG-I 炎性小体抑制抗病毒免疫并促进哮喘和 COVID-19 中的炎症。
Nat Commun. 2023 Apr 22;14(1):2329. doi: 10.1038/s41467-023-37470-4.
8
Mitochondrial damage activates the NLRP10 inflammasome.线粒体损伤激活NLRP10炎性小体。
Nat Immunol. 2023 Apr;24(4):595-603. doi: 10.1038/s41590-023-01451-y. Epub 2023 Mar 20.
9
A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies.一项针对多种疾病修正治疗药物治疗的多发性硬化症患者对 COVID-19 加强疫苗接种的细胞免疫反应的前瞻性研究。
J Neurol. 2023 May;270(5):2380-2391. doi: 10.1007/s00415-023-11575-8. Epub 2023 Mar 18.
10
Celastrol attenuates hepatitis C virus translation and inflammatory response in mice by suppressing heat shock protein 90β.藜芦醇通过抑制热休克蛋白 90β 来减轻小鼠丙型肝炎病毒的翻译和炎症反应。
Acta Pharmacol Sin. 2023 Aug;44(8):1637-1648. doi: 10.1038/s41401-023-01067-w. Epub 2023 Mar 7.